SCHEMBL21394554

SCHEMBL21394554

O=C(Nc1ccc(C(F)(F)F)cc1Cl)c1cc(Br)c(F)cc1NS(=O)(=O)C1CC1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MRGPRX1 Q96LB2 10/20 0.49
TMPRSS4 Q9NRS4 1/20 0.43
TRPV1 Q8NER1 1/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
TSPO P30536 1/20 0.43
SMO Q99835 1/20 0.42
HRH1 P35367 1/20 0.41
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
TP53 P04637 1/20 0.39
CCKBR P32239 1/20 0.39
AVPR2 P30518 1/20 0.39
GPR27 Q9NS67 1/20 0.39
KCNK2 O95069 1/20 0.38
KCNK10 P57789 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21394560 0.91 MRGPRX1 (0.51) MRGPRX1TMPRSS4TRPV1CA12CA1
SCHEMBL21394555 0.89 MRGPRX1 (0.49) MRGPRX1TMPRSS4TRPV1TSPOHRH1
SCHEMBL21394417 0.87 MRGPRX1 (0.53) MRGPRX1TMPRSS4TRPV1CA12CA1
SCHEMBL21384576 0.86 MRGPRX1 (0.63) MRGPRX1TMPRSS4CA12CA1CA2
SCHEMBL21394420 0.85 MRGPRX1 (0.56) MRGPRX1TMPRSS4TRPV1CA12CA1
SCHEMBL21394415 0.82 MRGPRX1 (0.61) MRGPRX1TMPRSS4TSPOHRH1
SCHEMBL21394361 0.81 MRGPRX1 (0.58) MRGPRX1TMPRSS4CA12CA1CA2
SCHEMBL21381353 0.81 MRGPRX1 (0.62) MRGPRX1TMPRSS4TRPV1TSPOHRH1
SCHEMBL21384571 0.77 MRGPRX1 (0.60) MRGPRX1TMPRSS4TSPOHRH1RAB9A
SCHEMBL18341272 0.74 TMPRSS4 (0.54) MRGPRX1TMPRSS4TRPV1CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019179436-A1 ACID AMIDE COMPOUND AND USE THEREOF IN TREATMENT OF CANCERS 成都海创药业有限公司 2019-09-26 WO disclosed